Update shared on 22 Dec 2025
Analysts have raised their price target on Goldwind Science&Technology slightly to 17.37, reflecting a modestly lower discount rate and marginally improved expectations for long term profitability and valuation multiples.
What's in the News
- Shareholders at the 19 December 2025 extraordinary general meeting approved amendments to Goldwind Science & Technology's Articles of Association, signaling formal changes to the company bylaws (company filing).
- The 19 December 2025 extraordinary shareholders meeting agenda included the proposed repurchase and cancellation of certain restricted shares, a change in registered capital and articles, and approval of the 2026 continuing connected transaction quota for A shares (company meeting notice).
- On 21 November 2025, the board approved a plan to repurchase and cancel 1,279,000 restricted shares, reducing total share capital and registered capital slightly and updating the Articles of Association to reflect the new share structure (board resolution).
- A board meeting held on 24 October 2025 reviewed and approved the unaudited financial results for the nine months ended 30 September 2025, along with other routine business matters (board meeting agenda).
- At a 30 May 2025 board meeting, directors considered an application to register and issue long term option embedded medium term bonds, indicating potential new funding via the domestic debt market (board meeting agenda).
Valuation Changes
- Fair Value: unchanged at CN¥17.37 per share, indicating no revision to the central valuation estimate.
- Discount Rate: fallen slightly from 11.72 percent to 11.37 percent, reflecting a modest reduction in the perceived risk profile or required return.
- Revenue Growth: effectively unchanged at around 15.96 percent, suggesting stable assumptions for top line expansion.
- Net Profit Margin: effectively unchanged at about 5.63 percent, implying no material adjustment to long term profitability expectations.
- Future P/E: edged down slightly from 16.88x to 16.72x, pointing to a marginally lower valuation multiple applied to future earnings.
Have other thoughts on Goldwind Science&Technology?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
